A detailed history of Nomura Asset Management CO LTD transactions in Johnson & Johnson stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 1,624,842 shares of JNJ stock, worth $237 Million. This represents 0.83% of its overall portfolio holdings.

Number of Shares
1,624,842
Previous 1,432,016 13.47%
Holding current value
$237 Million
Previous $209 Million 25.81%
% of portfolio
0.83%
Previous 0.72%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$145.48 - $167.38 $28.1 Million - $32.3 Million
192,826 Added 13.47%
1,624,842 $263 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $7.14 Million - $7.8 Million
49,432 Added 3.58%
1,432,016 $209 Million
Q1 2024

May 13, 2024

SELL
$155.22 - $162.74 $117,035 - $122,705
-754 Reduced 0.05%
1,382,584 $219 Million
Q4 2023

Feb 09, 2024

BUY
$145.6 - $158.88 $8.95 Million - $9.76 Million
61,445 Added 4.65%
1,383,338 $217 Million
Q3 2023

Nov 03, 2023

SELL
$155.75 - $174.48 $34.5 Million - $38.7 Million
-221,672 Reduced 14.36%
1,321,893 $206 Million
Q2 2023

Aug 14, 2023

BUY
$154.35 - $166.11 $36.8 Million - $39.6 Million
238,304 Added 18.26%
1,543,565 $255 Million
Q1 2023

May 11, 2023

BUY
$151.05 - $180.26 $15.6 Million - $18.6 Million
103,393 Added 8.6%
1,305,261 $202 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $15.9 Million - $17.8 Million
-99,195 Reduced 7.62%
1,201,868 $212 Million
Q3 2022

Nov 10, 2022

BUY
$161.33 - $179.52 $7.71 Million - $8.58 Million
47,802 Added 3.81%
1,301,063 $213 Million
Q2 2022

Aug 12, 2022

SELL
$168.19 - $186.01 $23 Million - $25.4 Million
-136,710 Reduced 9.84%
1,253,261 $222 Million
Q1 2022

May 13, 2022

BUY
$158.14 - $179.59 $23 Million - $26.1 Million
145,533 Added 11.69%
1,389,971 $246 Million
Q4 2021

Feb 01, 2022

SELL
$155.93 - $173.01 $6.03 Million - $6.69 Million
-38,675 Reduced 3.01%
1,244,438 $213 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $10.5 Million - $11.6 Million
64,752 Added 5.31%
1,283,113 $207 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $5.18 Million - $5.55 Million
32,461 Added 2.74%
1,218,361 $201 Million
Q1 2021

May 14, 2021

BUY
$153.07 - $170.48 $1.93 Million - $2.15 Million
12,604 Added 1.07%
1,185,900 $195 Million
Q4 2020

Feb 12, 2021

BUY
$137.11 - $157.38 $17.7 Million - $20.3 Million
129,181 Added 12.37%
1,173,296 $185 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $571,908 - $626,703
-4,074 Reduced 0.39%
1,044,115 $155 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $7.61 Million - $9.19 Million
-59,116 Reduced 5.34%
1,048,189 $147 Million
Q1 2020

May 14, 2020

BUY
$111.14 - $153.99 $1.74 Million - $2.41 Million
15,678 Added 1.44%
1,107,305 $145 Million
Q4 2019

Feb 13, 2020

BUY
$127.5 - $146.44 $8.89 Million - $10.2 Million
69,718 Added 6.82%
1,091,627 $159 Million
Q3 2019

Nov 13, 2019

BUY
$126.95 - $142.14 $22.3 Million - $25 Million
175,756 Added 20.77%
1,021,909 $132 Million
Q2 2019

Aug 13, 2019

SELL
$131.15 - $144.24 $13.3 Million - $14.6 Million
-101,097 Reduced 10.67%
846,153 $118 Million
Q1 2019

May 10, 2019

BUY
$125.72 - $139.79 $5,154 - $5,731
41 Added 0.0%
947,250 $132 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $1.65 Million - $1.99 Million
-13,449 Reduced 1.4%
947,209 $122 Million
Q3 2018

Nov 07, 2018

BUY
$121.58 - $142.88 $951,971 - $1.12 Million
7,830 Added 0.82%
960,658 $133 Million
Q2 2018

Aug 03, 2018

SELL
$119.4 - $131.76 $11.9 Million - $13.1 Million
-99,300 Reduced 9.44%
952,828 $116 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $5.17 Million - $6.12 Million
41,325 Added 4.09%
1,052,128 $135 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $5.59 Million - $6.12 Million
42,608 Added 4.4%
1,010,803 $141 Million
Q3 2017

Nov 13, 2017

BUY
$129.47 - $135.38 $17.4 Million - $18.2 Million
134,575 Added 16.14%
968,195 $126 Million
Q2 2017

Aug 14, 2017

BUY
N/A
833,620
833,620 $110 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $381B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.